World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
25365
World Ranking
1673
National Ranking
824

Medicine

D-Index
79
Citations
25365
World Ranking
17472
National Ranking
8747

Overview

Deborah L. Birx is affiliated with the Centers for Disease Control and Prevention in the United States and has conducted research primarily within the field of Medicine. Their work spans several subfields, including Infectious Diseases, Ecology, Epidemiology, Virology, and Molecular Biology. The research topics covered prominently relate to HIV/AIDS, including research and interventions, drug development and treatment, as well as aspects of genomics and phylogenetic studies. Other notable topics include bacteriophages and microbial interactions and adolescent sexual and reproductive health.

Key recent publications by Deborah L. Birx include:

  • Global and regional epidemiology of HIV-1 recombinants in 1990-2015: a systematic review and global survey, 2020, The Lancet HIV
  • Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study, 2021, Frontiers in Microbiology
  • The evolution of DREAMS: using data for continuous program improvement, 2022, AIDS
  • Modeling DREAMS impact: trends in new HIV diagnoses among women attending antenatal care clinics in DREAMS countries, 2022, AIDS
  • Cryo-EM analysis of Pseudomonas phage Pa193 structural components, 2024, Communications Biology

The frequent co-authors associated with their research include Chun-Feng David Hou, A.B. Soriaga, Lucy Sim, Pierre Kyme, and Sébastien Lemire.

Publications by Deborah L. Birx have appeared in various academic venues with multiple contributions in the American Journal of Infection Control, AIDS, and bioRxiv (Cold Spring Harbor Laboratory). Other outlets include The Lancet HIV and Frontiers in Microbiology.

Best Publications

  • Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

    Supachai Rerks-Ngarm;Punnee Pitisuttithum;Sorachai Nitayaphan;Jaranit Kaewkungwal

  • Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

    John R. Mascola;Gabriela Stiegler;Thomas C. VanCott;Hermann Katinger

  • Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies

    John R. Mascola;Mark G. Lewis;Gabriela Stiegler;Dawn Harris

  • DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells

    Boonrat Tassaneetrithep;Boonrat Tassaneetrithep;Timothy H. Burgess;Angela Granelli-Piperno;Christine Trumpfheller

  • Human skin Langerhans cells are targets of dengue virus infection.

    Shuenn-Jue L. Wu;Geraldine Grouard-Vogel;Wellington Sun;John R. Mascola

  • The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression

    N. L. Michael;G. Chang;L. G. Louie;J. R. Mascola

  • Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters

    Nathan D. Wolfe;Walid Heneine;Jean K. Carr;Albert D. Garcia

  • Naturally acquired simian retrovirus infections in central African hunters

    Nathan D Wolfe;William M Switzer;Jean K Carr;Vinod B Bhullar

  • Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.

    Deborah L. Birx;Robert R. Redfield;Giovanna Tosato

  • A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.

    Jeffrey R Currier;Ellen G Kuta;Ellen Turk;Lyndsay B Earhart

  • Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

    Joris Hemelaar;Ramyiadarsini Elangovan;Jason Yun;Leslie Dickson-Tetteh

  • Effect of Human Immunodeficiency Virus Type 1 (HIV-1) Subtype on Disease Progression in Persons from Rakai, Uganda, with Incident HIV-1 Infection

    Noah Kiwanuka;Oliver Laeyendecker;Oliver Laeyendecker;Merlin Robb;Godfrey Kigozi

  • Full Genome Sequences of Human Immunodeficiency Virus Type 1 Subtypes G and A/G Intersubtype Recombinants

    Jean K. Carr;Mika O. Salminen;Jan Albert;Eric Sanders-Buell

  • A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus Infection

    Redfield Rr;Birx Dl;Ketter N;Tramont E

  • Induction of interleukin-6 during human immunodeficiency virus infection.

    Deborah L. Birx;Robert R. Redfield;Kathleen Tencer;Arnold Fowler

  • Epidemiologic and Biologic Characterization of a Cohort of Human Immunodeficiency Virus Type 1 Highly Exposed, Persistently Seronegative Female Sex Workers in Northern Thailand

    Chris Beyrer;Andrew W. Artenstein;Sungwal Rugpao;Henry Stephens

  • CD8 T-Cell Recognition of Multiple Epitopes within Specific Gag Regions Is Associated with Maintenance of a Low Steady-State Viremia in Human Immunodeficiency Virus Type 1-Seropositive Patients

    Christof Geldmacher;Jeffrey R. Currier;Eva Herrmann;Antelmo Haule

  • Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection.

    Bruce L. Levine;Wendy B. Bernstein;Wendy B. Bernstein;Naomi E. Aronson;Naomi E. Aronson;Katia Schlienger

  • Human dendritic cells as targets of dengue virus infection.

    Mary Marovich;Geraldine Grouard-Vogel;Mark Louder;Michael Eller

  • The World Health Organization African Region Laboratory Accreditation Process Improving the Quality of Laboratory Systems in the African Region

    Guy-Michel Gershy-Damet;Philip Rotz;David Cross;El Hadj Belabbes

  • Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America.

    Jean K. Carr;Maria Avila;Manuel Gomez Carrillo;Horacio Salomon

  • Laboratory systems and services are critical in global health: time to end the neglect?

    John N. Nkengasong;Peter Nsubuga;Okey Nwanyanwu;Guy-Michel Gershy-Damet

  • Biologic and Genetic Characterization of a Panel of 60 Human Immunodeficiency Virus Type 1 Isolates, Representing Clades A, B, C, D, CRF01_AE, and CRF02_AG, for the Development and Assessment of Candidate Vaccines

    Bruce K. Brown;Janice M. Darden;Sodsai Tovanabutra;Tamara Oblander

  • Dual Infection with Human Immunodeficiency Virus Type 1 of Distinct Envelope Subtypes in Humans

    Andrew W. Artenstein;Thomas C. VanCott;John R. Mascola;Jean K. Carr

  • Potent and Synergistic Neutralization of Human Immunodeficiency Virus (HIV) Type 1 Primary Isolates by Hyperimmune Anti-HIV Immunoglobulin Combined with Monoclonal Antibodies 2F5 and 2G12

    J R Mascola;M K Louder;T C VanCott;C V Sapan

  • Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus.

    N L Michael;G Chang;L A d'Arcy;P K Ehrenberg

  • Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1

    T.C. Vancott;V.R. Polonis;L.D. Loomis;N.L. Michael

Frequent Co-Authors

Francine E. McCutchan
Francine E. McCutchan Columbia University
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research
Robert R. Redfield
Robert R. Redfield Centers for Disease Control and Prevention
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Donald S. Burke
Donald S. Burke University of Pittsburgh
Josephine H. Cox
Josephine H. Cox National Institute of Allergy and Infectious Diseases
Victoria R. Polonis
Victoria R. Polonis Walter Reed Army Institute of Research
John R. Mascola
John R. Mascola ModeX Therapeutics
Sorachai Nitayaphan
Sorachai Nitayaphan Armed Forces Research Institute of Medical Science
Jerome H. Kim
Jerome H. Kim Walter Reed Army Institute of Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens up diverse career options in healthcare and research. Many students complement their immunology knowledge with nursing degrees to maximize their impact. For those interested in advancing clinical skills, exploring the fnp to acute care np bridge program can be a vital step, enabling a smooth transition from family nurse practitioner roles to acute care specialties.

For those beginning their nursing journey, the availability of online adn programs for non nurses provides accessible pathways to enter nursing without prior healthcare experience. Accelerated options like the accelerated fnp programs are also popular among students seeking fast-tracked Nurse Practitioner credentials.

Understanding financial prospects is crucial. Resources like the dnp salary by state offer valuable insights into regional earning potentials for Doctor of Nursing Practice graduates, helping students make informed decisions about their education and career trajectory in the immunology-healthcare nexus.

Best Scientists Citing Deborah L. Birx

Trending Scientists